G01N 2800/362
Menopause
G01N2800/362 (Menopause) appears on 5 US grants and 17 published applications in this corpus.
Search patents in G01N- Granted patents
- 5
- Published applications
- 17
- Assignees
- 10
- Inventors
- 44
- Latest grant
- 31 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 3 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 3 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone31 Dec 2024US 12,181,465 B2MFB Fertility, Inc.
- Method for evaluating urine of a subject to estimate the fertile window28 Sep 2021US 11,131,665 B1MFB Fertility, Inc.
- Methods for assessing vaginal atrophy18 Jul 2017US 9,706,951 B2The Procter & Gamble Company
- Diagnostic tests for abnormal ovarian conditions13 May 2014US 8,722,351 B2Rush University Medical Center
- Polypeptide and the use thereof17 May 2011US 7,943,580 B2National Cerebral and Cardiovascular Center
- Use of gdf-15 as a novel biomarker13 Aug 2026US 2026/0235622 A1
- Method for the assessment of perimenopause or menopause status via analysis of the igg glycome8 Feb 2024US 2024/0044917 A1GENOS d.o.o.
- Rapid multiplexed serological test23 Dec 2021US 2021/0396755 A1
- Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone16 Dec 2021US 2021/0389311 A1MFB Fertility, Inc.
- Method for evaluating urine of a subject to estimate the fertile window23 Sep 2021US 2021/0293800 A1MFB Fertility, Inc.
Most cited
By later US patents